Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06307431
Title A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN | AUS

Facility Status City State Zip Country Details
Yale-New Haven Hospital-Yale Cancer Center ( Site 0102) RECRUITING New Haven Connecticut 06510 United States Details
Memorial Sloan Kettering Cancer Center ( Site 0100) RECRUITING New York New York 10065 United States Details
Macquarie University-MQ Health Clinical Trials Unit ( Site 1502) RECRUITING Macquarie University New South Wales 2109 Australia Details
CHU de Quebec - Université Laval - Hotel Dieu de Quebec ( Site 0008) RECRUITING Québec Quebec G1R 2J6 Canada Details
FALP-UIDO ( Site 1202) RECRUITING Santiago Region M. De Santiago 7500921 Chile Details
Pontificia Universidad Catolica de Chile-Centro del Cáncer ( Site 1205) RECRUITING Santiago Region M. De Santiago 8330032 Chile Details
Bradfordhill-Clinical Area ( Site 1201) RECRUITING Santiago Region M. De Santiago 8420383 Chile Details
ONCOCENTRO APYS-ACEREY ( Site 1200) RECRUITING Viña del Mar Valparaiso 2520598 Chile Details
Taipei Veterans General Hospital ( Site 1703) RECRUITING Taipei 112 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field